KLRK1 and neoplasm: Hence, upregulation of stress-inducible NKG2D ligand in tumor cells and NKG2D receptor in tumor-infiltrating immune cells can help to orchestrate concerted NKG2D-mediated NK, CD8+ αβ, and γδ T-cell anti-tumor responses within the TME.